A Pennsylvania man has shown significant improvement in mobility after participating in an experimental drug trial for spinal cord injury treatment.
Larry Williams, a 58-year-old man from Philadelphia, was able to walk again after being paralyzed in a mountain biking accident.
Williams shared his experience with the experimental NVG-291 trial, stating that the injectable peptide has helped him move more freely after his accident.
The NVG-291 trial has been tested in a phase 2 trial with eligible patients, resulting in remarkable outcomes for some participants.
Author's summary: Experimental drug helps paralyzed man walk again.